Anteris Technologies Global Corp. (AVR) vs Anbio Biotechnology (NNNN)

Anteris Technologies Global Corp. and Anbio Biotechnology are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $884.9M against $745.6M — 1.2× the size. Across the 8 metrics below, Anbio Biotechnology leads on 8 and Anteris Technologies Global Corp. on 0.

Valuation

Metric AVR NNNN Medical Instruments & Supplies median
P/E n/m — 34.17
P/S 333.87 — 2.83
P/B 2.97 n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 219.27 n/m 3.06
Earnings yield (25.36%) — (1.84%)
Free cash flow yield (11.79%) 0.00% 0.17%

Profitability

Metric AVR NNNN Medical Instruments & Supplies median
Gross margin 74.98% — 54.62%
Operating margin (4,738.36%) — 1.64%
Net margin (4,619.27%) — 0.00%
Free cash flow margin (3,937.07%) 0.00% 1.61%
Return on equity (75.13%) 0.00% 0.00%
Return on assets (66.31%) 0.00% 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVR NNNN Medical Instruments & Supplies median
Revenue growth (TTM) (9.56%) — 9.20%
EPS growth (last fiscal year) 30.71% 150.00% —
Revenue growth, 5-year CAGR — — 9.48%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric AVR NNNN Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 14.20 344.45 2.49
Net debt to EBITDA 0.14 (2.06) 0.83

Dividend

Metric AVR NNNN Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio — — 0.00

Size

Metric AVR NNNN Medical Instruments & Supplies median
Market cap 745.56m 884.93m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack